HavenGarberMD

PubMed

• Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer.
  Sreyashi Basu, Sonali Jindal, Zhong He, Khoi Chu, Akshara Singareeka Raghavendra, Haven R Garber, Clinton Yam, Lumarie Santiago, Beatriz E Adrada, Padmanee Sharma, Eli...> ;Oncotarget. 2024 Mar 19
• Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement.
  Susie X Sun, Matthew J Piotrowski, Taiwo Adesoye, Melissa P Mitchell, Haven R Garber, Mediget Teshome, Henry M Kuerer, Nina Tamirisa, Puneet Singh> ;Journal of the American College of Surgeons. 2024 Jan 1
• 2 citations
  A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
  Clinton Yam, Elizabeth A Mittendorf, Haven R Garber, Ryan Sun, Senthil Damodaran, Rashmi K Murthy, David Ramirez, Meghan Karuturi, Rachel M Layman, Nuhad Ibrahim, Gaia...> ;Breast Cancer Research and Treatment. 2023 Jun 1
• 2 citations
  Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with ...
  Tapsi Kumar, Evie Hobbs, Fei Yang, Jeffrey T Chang, Alejandro Contreras, Edwin Roger Parra Cuentas, Haven Garber, Sanghoon Lee, Yiling Lu, Marion E Scoggins, Beatriz E...> ;Clinical Cancer Research. 2022 Sep 1
• 8 citations
  Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer.
  Haven R Garber, Akshara Singareeka Raghavendra, Michael Lehner, Wei Qiao, Angelica M Gutierrez-Barrera, Debu Tripathy, Banu Arun, Nuhad K Ibrahim> ;NPJ Breast Cancer. 2022 Apr 7
• 25 citations
  Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.
  Clinton Yam, Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber, Lei Huo, Fei Yang, Anne V. Philips, Qingqing Ding, Bora Lim, Naoto T. U...> ;Clinical Cancer Research. 2021 Jul 12
• 6 citations
  Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancer.
  Haven R. Garber, Jennifer K. Litton> ;Current Opinion in Oncology. 2019 May 1
• 15 citations
  Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes
  Gheath Alatrash, Na Qiao, Mao Zhang, Madhushree Zope, Alexander A. Perakis, Pariya Sukhumalchandra, Anne V. Philips, Haven R. Garber, Celine Kerros, Lisa S. St. John, ...> ;Clinical Cancer Research. 2019 Apr 15
• 23 citations
  Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation
  Tian Hui Yang, Lisa S. St. John, Haven R. Garber, Celine Kerros, Kathryn Ruisaard, Karen Clise-Dwyer, Gheath Alatrash, Qing Ma, Jeffrey J. Molldrem> ;Journal of Immunology. 2018 Sep 1
• 2 citations
  Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
  Gheath Alatrash, Alexander A. Perakis, Celine Kerros, Haley L. Peters, Pariya Sukhumalchandra, Mao Zhang, Haroon Jakher, Madhushree Zope, Rebecca Patenia, Anna Sergeev...> ;Clinical Cancer Research. 2018 Apr 16
• 109 citations
  Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
  Alexandre Reuben, Christine N. Spencer, Peter A. Prieto, Vancheswaran Gopalakrishnan, Sangeetha M. Reddy, John P. Miller, Xizeng Mao, Mariana Petaccia de Macedo, Jiong...> ;NPJ Genomic Medicine. 2017 Apr 7
• 12 citations
  Serine proteases enhance immunogenic antigen presentation on lung cancer cells
  Haley L. Peters, Satyendra C. Tripathi, Celine Kerros, Hiroyuki Katayama, Haven R. Garber, Lisa S. St. John, Lorenzo Federico, Ismail M. Meraz, Jack A. Roth, Boris Sep...> ;Cancer Immunology Research. 2017 Mar 2
• 20 citations
  Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
  Gheath Alatrash, Haven R. Garber, Minying Zhang, Pariya Sukhumalchandra, Yihua Qiu, Haroon Jakher, Alexander A. Perakis, Lisa M. Becker, Suk-Young Yoo, Karen C. Dwyer,...> ;Leukemia. 2017 Jan 1
• 14 citations
  Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leuke...
  Gheath Alatrash, Peter F. Thall, Benigno C. Valdez, Patricia S. Fox, Jing Ning, Haven R. Garber, Selma Janbey, Laura L. Worth, Uday R. Popat, Chitra Hosing, Amin M. Al...> ;Biology of Blood and Marrow Transplantation. 2016 Oct 1
• 68 citations
  A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells
  Qing Ma, Haven R. Garber, Sijie Lu, Hong He, Eran Tallis, Xiaoling Ding, Anna Sergeeva, Michael Scott Wood, Gianpietro Dotti, Barbara Salvado, Kathryn Ruisaard, Karen ...> ;Cytotherapy. 2016 Aug 1
• 9 citations
  PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.
  Lisa S. St. John, Liping Wan, Hong He, Haven R. Garber, Karen Clise-Dwyer, Gheath Alatrash, Katayoun Rezvani, Elizabeth J. Shpall, Catherine M. Bollard, Qing Ma, Jeffr...> ;Cytotherapy. 2016 Aug 1
• 10 citations
  Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL.
  Yongzhi Cui, Masahiro Onozawa, Haven R. Garber, Leigh Samsel, Ziyao Wang, J. Philip McCoy, Sandra Burkett, Xiaolin Wu, Peter D. Aplan, Crystal L. Mackall> ;Blood. 2015 May 7
• 14 citations
  Adoptive T-cell therapy for Leukemia
  Haven R. Garber, Asma Mirza, Elizabeth A. Mittendorf, Gheath Alatrash> ;Molecular and Cellular Therapies. 2014 Aug 12
• 16 citations
  Targeting the MAGE A3 antigen in pancreatic cancer
  Alexandria P. Cogdill, Dennie T. Frederick, Zachary A. Cooper, Haven R. Garber, Cristina R. Ferrone, Amy G. Fiedler, Laura Rosenberg, Sarah P. Thayer, Andrew L. Warsha...> ;Surgery. 2012 Sep 1
• Join now to see all

Lectures

• Brain metastasis in patients with hereditary mutated invasive breast cancer. 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019